---
document_datetime: 2025-06-05 09:35:27
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/efmody-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: efmody-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.69834
conversion_datetime: 2025-12-31 04:06:51.08355
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Efmody

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                          |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0013              | Update of sections 4.2, 4.4, 4.5, and 4.8 of the SmPC based on the pooled safety analysis of DIUR- 006; this is a phase 3 extension study of efficacy, safety and tolerability of hydrocortisone in the treatment of congenital adrenal hyperplasia. The Package Leaflet is updated accordingly. In addition, | 27/03/2025                          |                                             | SmPC and PL                      | The SmPC has been amended to better explain the potential effects of the drug on the electrolytes balance, as well as its impact on the results of investigations. For more information, please refer to the Summary of Product Characteristics. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             | the MAH took the opportunity to introduce editorial changes to the PI. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance                                                                                                                                                                                                                                                                                                                           |            |     |                                  | data          |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------|---------------|
| IB/0011/G   | This was an application for a group of variations. C.I.7.b - Deletion of - a strength A.7 - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                                                                                                         | 05/12/2024 |     | SmPC, Annex II, Labelling and PL | manufacturing |
| IAIN/0012   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                    | 14/11/2024 |     | SmPC, Labelling and PL           |               |
| WS/2740/G   | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 03/10/2024 | n/a |                                  |               |
| IAIN/0009/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 06/08/2024 |     | Annex II and                     |               |

<div style=\"page-break-after: always\"></div>

|                    | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site   |            |            | PL          |                                                                                                                        |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------|
| IA/0008            | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                 | 09/05/2024 | n/a        |             |                                                                                                                        |
| IA/0007            | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                  | 24/01/2024 | n/a        |             |                                                                                                                        |
| IA/0006            | B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer                                                                                                                                                                                                                  | 27/09/2023 | n/a        |             |                                                                                                                        |
| PSUSA/9176/ 202211 | Periodic Safety Update EU Single assessment - hydrocortisone (for centrally authorised products for adrenal insufficiency, congenital adrenal hyperplasia,                                                                                                                                                                                                                                                                                   | 22/06/2023 | 23/08/2023 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<div style=\"page-break-after: always\"></div>

|             | modified-release formulations)                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                        |                              |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------|
| IB/0004/G   | application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside currently approved pack sizes                                                            | 21/06/2022 | 29/06/2023 | SmPC, Labelling and PL | This was an the range of the |
| IA/0002     | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                                                                                                                                                                                                                                                                          | 10/05/2022 | n/a        |                        |                              |
| IAIN/0001/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging | 08/06/2021 | 08/07/2022 | SmPC, Annex II and PL  | site                         |